Balyasny Asset Management LLC Athersys, Inc Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.18 - $0.86 $6,967 - $33,289	38,709 New	38,709 $10,000
Q3 2021 Nov 15, 2021	SELL	$1.33 - $1.77 $154,439 - $205,532	-116,120 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.41 - $1.94 $163,729 - $225,272	116,120 New	116,120 $167,000
Q3 2018 Nov 14, 2018	SELL	$1.86 - $2.18 $30,773 - $36,068	-16,545 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$1.76 - $2.79 $31,868 - $50,518	-18,107 Reduced 52.25%	16,545 $33,000
Q1 2018 May 15, 2018	BUY	$1.34 - $2.03 $6,298 - $9,540	4,700 Added 15.69%	34,652 $63,000
Q4 2017 Feb 14, 2018	BUY	$1.65 - $2.45 $49,420 - $73,382	29,952	29,952 $54,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.